Want to create an interactive transcript for this episode?
Podcast: Investor Connect Podcast
Episode: Startup Funding Espresso – The Myths of Biotech Investing
Description: The Myths of Biotech Investing Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing. Biotech investing differs from tech investing. There’s often no revenue traction to assess. The startup must navigate the FDA path while dealing with cutting-edge devices and therapeutics. Here are some myths of biotech investing: Myth 1-Biotech startups are building companies. In many cases, the biotech startup will sell during the clinical trials or at FDA approval. They rarely proceed to launching a business. Myth 2- Biotechs take much longer than tech companies to exit. Mo...